David Katz to Male
This is a "connection" page, showing publications David Katz has written about Male.
Connection Strength
0.323
-
Katz DE, Leibner G, Kaufman N, Esayag Y, Brammli-Greenberg S, Rose AJ. Improving Discrimination in Predicting Level of Care Needed for Patients Admitted with Pneumonia. J Gen Intern Med. 2025 Sep; 40(13):3051-3057.
Score: 0.055
-
Ben-Chetrit E, Bnaya A, Barchad OW, Vedder K, Katz DE. Chloramphenicol treatment revisited - demographics, clinical characteristics, and outcomes of hospitalized patients. Eur J Clin Microbiol Infect Dis. 2024 Aug; 43(8):1667-1671.
Score: 0.051
-
Mendlovic J, Weiss G, Da'as N, Yinnon A, Katz DE. Internal medicine patients admitted without COVID-19 during the outbreak. Int J Clin Pract. 2020 Dec; 74(12):e13630.
Score: 0.039
-
Ben-Chetrit E, Eldaim MA, Bar-Meir M, Dodin M, Katz DE. Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum ?-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia. Int J Antimicrob Agents. 2019 Apr; 53(4):423-428.
Score: 0.035
-
Katz DE, Shanek O, Raveh-Brawer D, Yinnon AM, Munter G. [SELECTING A SPECIALTY BY INTERNS IN A CHANGING PERIOD: A MULTI-YEAR AND SINGLE-CENTER EXPERIENCE]. Harefuah. 2018 Jun; 157(6):356-360.
Score: 0.034
-
Katz DE, Friedman ND, Ostrovski E, Ravid D, Amrami N, Avivi D, Mengesha B, Zaidenstein R, Lazarovitch T, Dadon M, Marchaim D. Diabetic foot infection in hospitalized adults. J Infect Chemother. 2016 Mar; 22(3):167-73.
Score: 0.029
-
Katz DE, Martone WJ. Community-phenotype-methicillin-resistant Staphylococcus aureus infections: a retrospective chart review of outcomes after treatment with daptomycin. Clin Ther. 2007 Nov; 29(11):2440-7.
Score: 0.016
-
Leibner G, Katz DE, Esayag Y, Kaufman N, Brammli-Greenberg S, Rose AJ. Incorporating clinical and demographic data into the Elixhauser Comorbidity Model: deriving and validating an enhanced model in a tertiary hospital's internal medicine department. BMC Health Serv Res. 2024 Dec 05; 24(1):1523.
Score: 0.013
-
Katz DE, DeLorimier AJ, Wolf MK, Hall ER, Cassels FJ, van Hamont JE, Newcomer RL, Davachi MA, Taylor DN, McQueen CE. Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen. Vaccine. 2003 Jan 17; 21(5-6):341-6.
Score: 0.012
-
Shpunt Y, Estrin I, Levi Y, Saadon H, Ben-Yossef G, Goldshtein L, Klafter D, Zilberman-Itskovich S, Ben-David D, Katz DE, Lazarovitch T, Zaidenstein R, Marchaim D. Antimicrobial use for asymptomatic bacteriuria-First, do no harm. Infect Control Hosp Epidemiol. 2021 01; 42(1):37-42.
Score: 0.010
-
Fay K, Sapiano MRP, Gokhale R, Dantes R, Thompson N, Katz DE, Ray SM, Wilson LE, Perlmutter R, Nadle J, Godine D, Frank L, Brousseau G, Johnston H, Bamberg W, Dumyati G, Nelson D, Lynfield R, DeSilva M, Kainer M, Zhang A, Ocampo V, Samper M, Pierce R, Irizarry L, Sievers M, Maloney M, Fiore A, Magill SS, Epstein L. Assessment of Health Care Exposures and Outcomes in Adult Patients With Sepsis and Septic Shock. JAMA Netw Open. 2020 07 01; 3(7):e206004.
Score: 0.010
-
Ben-Chetrit E, Weiner-Well Y, Katz DE, Rosenman D, Munter G. Ventricular Septal Defect Associated Right-sided Infective Endocarditis Complicated by Septic Pulmonary Emboli. Am J Med Sci. 2016 Jul; 352(1):107-8.
Score: 0.007
-
Rehm S, Campion M, Katz DE, Russo R, Boucher HW. Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy. J Antimicrob Chemother. 2009 May; 63(5):1034-42.
Score: 0.004
-
Krige JE, Lindfield K, Friedrich L, Otradovec C, Martone WJ, Katz DE, Tally F. Effectiveness and duration of daptomycin therapy in resolving clinical symptoms in the treatment of complicated skin and skin structure infections. Curr Med Res Opin. 2007 Sep; 23(9):2147-56.
Score: 0.004
-
Orr N, Katz DE, Atsmon J, Radu P, Yavzori M, Halperin T, Sela T, Kayouf R, Klein Z, Ambar R, Cohen D, Wolf MK, Venkatesan MM, Hale TL. Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers. Infect Immun. 2005 Dec; 73(12):8027-32.
Score: 0.004